Towards Healthcare
Gene Therapy Market Size Hits USD 11.4 Billion in 2025

Gene Therapy Market in 2025 Hospitals Lead with 65% Share as R&D and Strategic Investments Drive 20% CAGR

Market insights predict the global gene therapy industry will increase from USD 9.5 billion in 2024 to USD 58.87 billion by 2034, achieving a CAGR of 20%. The gene therapy market is growing rapidly due to the growing demand for precision medicine. North America’s dominance is attributed to the rising focus on genomics & multi-omics.

Content

  • Insight Code: 5804
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

Talk to us
FAQ's

The gene therapy market is projected to reach USD 58.87 billion by 2034, growing at a CAGR of 20% from 2024 to 2034.

North America is currently leading the gene therapy market due to rising cases of chronic conditions and growing investments in multi-omics.

The gene therapy market includes seven segments such as by therapy type, by vector type, by gene type, by disease indication, by delivery method, by end-user, and by region.

Some key players include Amgen Inc., Novartis AG, F. Hoffmann-La Roche, Gilead Sciences, Inc., bluebird bio, Inc., etc.

Key trends include rising prevalence of cancer, growing demand for personalized medicine, and rising research in genomics.

By repairing the underlying genetic fault, gene therapy may provide a permanent cure for certain genetic disorders. however, the effectiveness of this treatment will vary depending on the condition, the mode of administration, and the stability of the implanted gene.

By 2036, genetic treatments are predicted to be the norm for treating uncommon genetic disorders, and they will finally be able to cure them.  Additionally, CRISPR-Cas9 is thought to be the most promising gene editing technique for replacing or repairing damaged genes within the next 15 years.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions